Australia's CSL to start work on immunoglobulin product to treat COVID-19

Australian biotech firm CSL Ltd said on Wednesday it will start local development of an immunoglobulin product to treat serious cases of COVID-19, the disease caused by the novel coronavirus.

from Reuters: Company News https://ift.tt/2A45l59
via IFTTT